160 related articles for article (PubMed ID: 7689973)
1. Biphasic displacement of [3H]YM-09151-2 binding in the rat brain by thioridazine, risperidone and clozapine, but not by other antipsychotics.
Assié MB; Sleight AJ; Koek W
Eur J Pharmacol; 1993 Jun; 237(2-3):183-9. PubMed ID: 7689973
[TBL] [Abstract][Full Text] [Related]
2. Differential in vivo inhibition of [3H]nemonapride binding by atypical antipsychotics in rat striatum, olfactory lobes, and frontal cortex.
Assié MB; Consul-Denjean N; Koek W; Newman-Tancredi A
Pharmacology; 2005 Oct; 75(2):63-8. PubMed ID: 16020947
[TBL] [Abstract][Full Text] [Related]
3. Binding of antipsychotic drugs at alpha 1A- and alpha 1B-adrenoceptors: risperidone is selective for the alpha 1B-adrenoceptors.
Sleight AJ; Koek W; Bigg DC
Eur J Pharmacol; 1993 Jul; 238(2-3):407-10. PubMed ID: 7691623
[TBL] [Abstract][Full Text] [Related]
4. Dopamine D2 receptors selectively labeled by a benzamide neuroleptic: [3H]-YM-09151-2.
Niznik HB; Grigoriadis DE; Pri-Bar I; Buchman O; Seeman P
Naunyn Schmiedebergs Arch Pharmacol; 1985 Jun; 329(4):333-43. PubMed ID: 2863760
[TBL] [Abstract][Full Text] [Related]
5. Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity.
Leysen JE; Janssen PM; Megens AA; Schotte A
J Clin Psychiatry; 1994 May; 55 Suppl():5-12. PubMed ID: 7520908
[TBL] [Abstract][Full Text] [Related]
6. Autoradiography of dopamine D2 receptors using [3H]YM-09151-2.
Cox RF; Waszczak BL
Eur J Pharmacol; 1991 Jun; 199(1):103-6. PubMed ID: 1680055
[TBL] [Abstract][Full Text] [Related]
7. Characterization of typical and atypical antipsychotic drugs based on in vivo occupancy of serotonin2 and dopamine2 receptors.
Stockmeier CA; DiCarlo JJ; Zhang Y; Thompson P; Meltzer HY
J Pharmacol Exp Ther; 1993 Sep; 266(3):1374-84. PubMed ID: 8103793
[TBL] [Abstract][Full Text] [Related]
8. In vivo dopamine-D2 and serotonin-5-HT2 receptor binding study of risperidone and haloperidol.
Sumiyoshi T; Kido H; Sakamoto H; Urasaki K; Suzuki K; Yamaguchi N; Mori H; Shiba K; Yokogawa K
Pharmacol Biochem Behav; 1994 Mar; 47(3):553-7. PubMed ID: 7516078
[TBL] [Abstract][Full Text] [Related]
9. Characterization of [3H]clozapine binding sites in rat brain.
Kusumi I; Matsubara S; Takahashi Y; Ishikane T; Koyama T
J Neural Transm Gen Sect; 1995; 101(1-3):51-64. PubMed ID: 8695057
[TBL] [Abstract][Full Text] [Related]
10. D2-dopamine receptor specific brain uptake of carbon-11-labeled YM-09151-2.
Hatano K; Ishiwata K; Kawashima K; Hatazawa J; Itoh M; Ido T
J Nucl Med; 1989 Apr; 30(4):515-22. PubMed ID: 2567779
[TBL] [Abstract][Full Text] [Related]
11. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.
Florijn WJ; Tarazi FI; Creese I
J Pharmacol Exp Ther; 1997 Feb; 280(2):561-9. PubMed ID: 9023264
[TBL] [Abstract][Full Text] [Related]
12. Effect of clozapine and risperidone on 5-HT2 and D2-dopamine receptor binding in the post-mortem human brain. An autoradiographic study.
Hall H; Halldin C; Nyberg S; Farde L; Sedvall G
Eur Neuropsychopharmacol; 1995 Mar; 5(1):19-25. PubMed ID: 7542051
[TBL] [Abstract][Full Text] [Related]
13. Critical reevaluation of spiperone and benzamide binding to dopamine D2 receptors: evidence for identical binding sites.
Malmberg A; Jerning E; Mohell N
Eur J Pharmacol; 1996 May; 303(1-2):123-8. PubMed ID: 8804920
[TBL] [Abstract][Full Text] [Related]
14. Clozapine occupies high levels of dopamine D2 receptors.
Seeman P; Kapur S
Life Sci; 1997; 60(12):PL 207-16. PubMed ID: 9061054
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo receptor binding and effects on monoamine turnover in rat brain regions of the novel antipsychotics risperidone and ocaperidone.
Leysen JE; Janssen PM; Gommeren W; Wynants J; Pauwels PJ; Janssen PA
Mol Pharmacol; 1992 Mar; 41(3):494-508. PubMed ID: 1372084
[TBL] [Abstract][Full Text] [Related]
16. Unique binding characteristics of antipsychotic agents interacting with human dopamine D2A, D2B, and D3 receptors.
Malmberg A; Jackson DM; Eriksson A; Mohell N
Mol Pharmacol; 1993 May; 43(5):749-54. PubMed ID: 8099194
[TBL] [Abstract][Full Text] [Related]
17. Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography.
Schotte A; Janssen PF; Megens AA; Leysen JE
Brain Res; 1993 Dec; 631(2):191-202. PubMed ID: 7510574
[TBL] [Abstract][Full Text] [Related]
18. Typical and atypical antipsychotic occupancy of D2 and S2 receptors: an autoradiographic analysis in rat brain.
Altar CA; Wasley AM; Neale RF; Stone GA
Brain Res Bull; 1986 Apr; 16(4):517-25. PubMed ID: 2872945
[TBL] [Abstract][Full Text] [Related]
19. The cloned dopamine D2 receptor reveals different densities for dopamine receptor antagonist ligands. Implications for human brain positron emission tomography.
Seeman P; Guan HC; Civelli O; Van Tol HH; Sunahara RK; Niznik HB
Eur J Pharmacol; 1992 Oct; 227(2):139-46. PubMed ID: 1358662
[TBL] [Abstract][Full Text] [Related]
20. Characterization of (125)I-IABN, a novel azabicyclononane benzamide selective for D2-like dopamine receptors.
Luedtke RR; Freeman RA; Boundy VA; Martin MW; Huang Y; Mach RH
Synapse; 2000 Dec; 38(4):438-49. PubMed ID: 11044891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
